Relay Therapeutics, Inc. (RLAY) Tops Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts RLAY Hot Sheet
Join SI Premium – FREE
Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q3 EPS of ($0.63), $0.14 better than the analyst estimate of ($0.77). Revenue for the quarter came in at $0 versus the consensus estimate of $88.89 thousand.
For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore ISI Starts Credo Tech (CRDO) at Outperform
- Goldman Sachs Reinstates Estee Lauder (EL) at Buy
- Stocks expected to have increasing option volume: SPCX FDX CCL MU ABBV APGE MTN
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
